*0011397068
*008050831s2005    xx#           000 0 eng
*019  $bk
*08230$a616.8982
*100  $aAndersen, T.H.$_158155800
*245  $aSwitching patients from olanzapine or risperidone to a combination treatment using perphenazine plus buspirone$bevaluation of antipsychotic efficacy and side-effects, including extrapyramidal effects and weight loss
*300  $aS. [205]-208
*500  $aVitenskapelig artikkel
*650  $aLegemiddelterapi$2norart$_58791800
*650  $abivirkninger$9nor$2norart$_128629700
*650  $aschizofreni$9nor$2norart$_128828500
*653  $aEPS$9eng$_158155900
*653  $abuspirone$9eng$_158156000
*653  $aclinical effects$9eng$_158156100
*653  $aolanzapine$9eng$_148593300
*653  $aperphenazine$9eng$_158156200
*653  $arisperidone$9eng$_128828900
*653  $aside-effects$9eng$_128829100
*653  $aweight loss$9eng$_132213500
*700  $aBech, P.$_158153600
*700  $aLarsen, N.-E.$_158156300
*773  $tNordic journal of psychiatry$gVol. 59, no. 3 (2005)$x0803-9488$w(NO-LaBS)36505(tnr)
*8564 $uhttps://doi.org/10.1080/08039480510027689
*999  $z500373551$anorart:500373551
^